Walkowiak J, Nousia-Arvanitakis S, Henker J, et al. Indirect pancreatic function tests in children. J Pediatr Gastroenterol Nutr 2005; 40: 107–114.
Borgo G, Mastella G, Gasparini P, et al. Pancreatic function and gene deletion F508 in cystic fibrosis. J Med Genet 1990; 27: 665–669.
Ahmed N, Corey M, Forstner G, et al. Molecular consequences of cystic fibrosis transmembrane regulator (CFTR) gene mutations in the exocrine pancreas. Gut 2003; 52: 1159–1164.
Kerem E, Kerem B. Genotype-phenotype correlations in cystic fibrosis. Pediatr Pulmonol 1996; 22: 387–395.
Cystic fibrosis genetic analysis consortium (Worldwide survey of the delta F508 mutation – report from the cystic fibrosis genetic analysis consortium. Am J Hum Genet 1990; 47: 354–359.
Santis G, Osborne L, Knight RA, et al. Independent genetic determinants of pancreatic and pulmonary status in cystic fibrosis. Lancet 1990; 336: 1081–1084.
K ristidis P, Bozon D, Corey M, et al. Genetic determination of exocrine pancreatic function in cystic fibrosis. Am J Hum Genet 1992; 50: 1178–1184.
The Cystic Fibrosis Genotype-Phenotype Consortium: Correlation between genotype and phenotype in patients with cystic fibrosis. N Eng J Med 1993; 329: 1308–1313.
Hubert D, Bienvenu T, Desmazes-Defeu N, et al. Genotype-phenotype relationships in a cohort of adult cystic fibrosis patients. Eur Respir J 1996; 9: 2207–2214.
Durno C, Corey M, Zielenski J, et al. Genotype and phenotype correlations in patients with cystic fibrosis and pancreatitis.Gastroenterology 2002; 123: 1857–1864.
Walkowiak J, Herzig KH, Witt M, et al. Analysis of exocrine pancreatic function in cystic fibrosis: one mild cft r mutation does not exclude pancreatic insufficiency. Eur J Clin Invest 2001; 31: 796–801.
Scheele GA, Fukuoka S-I, Kern HF, et al. Pancreatic dysfunction in cystic fibrosis occurs as a result of impairments in luminal pH, apical trafficking of zymogen granule membranes, and solubilization of secretory enzymes. Pancreas 1996; 12: 1–9.